MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy

K.J. Kim, J.-M. Kim (Seongnam-Si, Republic of Korea)

Meeting: 2017 International Congress

Abstract Number: 219

Keywords: Progressive supranuclear palsy(PSP), Urinary dysfunction pharmacological management of

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To compare the features of urinary dysfunction in Progressive supranuclear palsy (PSP) with those of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA).

Background: PSP can manifest urinary symptoms, like IPD and MSA do. However, urinary symptoms and its corresponding bladder dysfunctions in PSP have not been well studied to date. 

Methods: We conducted a retrospective analysis of urodynamic data in patients diagnosed of parkinsonian disorders (PSP, IPD, and MSA) and presented urinary symptoms. Clinical information including demographic factors, onset age, duration, severity, treatment of parkinsonism and urinary symptoms in each patients were collected. 

Results: A total of 131 patients (10 with PSP, 79 with IPD, and 42 with MSA) were included. The mean age and the age of disease onset of PSP patients were similar to those of IPD patients, and older than those of MSA patients. The duration of disease until the onset of urinary symptoms in PSP patients was similar to that of MSA patients, and shorter than that of IPD patients. In the urodynamic study, storage phase dysfunctions in patients with PSP were similar to those in patients with IPD or MSA. However, PSP patients showed the higher rates of voiding failure than IPD patients during a pressure-flow study and indicated the lower maximum flow rate, higher post-void residual volume, and higher proportions of impaired detrusor contraction than IPD patients, but rather similar to MSA patients. 

Conclusions: Patients with PSP have variable urinary dysfunctions as much as those with MSA do and have more severe voiding phase dysfunctions than those with IPD. This may reflect the extensive degenerative process of neural structure in patients with PSP.

To cite this abstract in AMA style:

K.J. Kim, J.-M. Kim. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/neurogenic-bladder-in-progressive-supranuclear-palsy-a-comparison-with-parkinsons-disease-and-multiple-system-atrophy/. Accessed July 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neurogenic-bladder-in-progressive-supranuclear-palsy-a-comparison-with-parkinsons-disease-and-multiple-system-atrophy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley